| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-177-01 | 50242-177 | HUMAN PRESCRIPTION DRUG | Lunsumio Velo | Mosunetuzumab | INJECTION | SUBCUTANEOUS | 20251219 | N/A | BLA | BLA761263 | Genentech, Inc. | MOSUNETUZUMAB | 5 mg/.5mL | 1 VIAL, GLASS in 1 CARTON (50242-177-01) / .5 mL in 1 VIAL, GLASS |
| 50242-159-01 | 50242-159 | HUMAN PRESCRIPTION DRUG | Lunsumio | Mosunetuzumab | CONCENTRATE | INTRAVENOUS | 20221222 | N/A | BLA | BLA761263 | Genentech, Inc. | MOSUNETUZUMAB | 1 mg/mL | 1 VIAL in 1 CARTON (50242-159-01) / 1 mL in 1 VIAL |
| 50242-201-01 | 50242-201 | HUMAN PRESCRIPTION DRUG | Lunsumio Velo | Mosunetuzumab | INJECTION | SUBCUTANEOUS | 20251219 | N/A | BLA | BLA761263 | Genentech, Inc. | MOSUNETUZUMAB | 45 mg/mL | 1 VIAL, GLASS in 1 CARTON (50242-201-01) / 1 mL in 1 VIAL, GLASS |
| 50242-142-01 | 50242-142 | HUMAN PRESCRIPTION DRUG | Lunsumio | Mosunetuzumab | CONCENTRATE | INTRAVENOUS | 20221222 | N/A | BLA | BLA761263 | Genentech, Inc. | MOSUNETUZUMAB | 30 mg/30mL | 1 VIAL in 1 CARTON (50242-142-01) / 30 mL in 1 VIAL |